Mitsubishi UFJ Trust & Banking Corp Raises Holdings in Stryker Corporation $SYK

Mitsubishi UFJ Trust & Banking Corp boosted its position in Stryker Corporation (NYSE:SYK) by 13.3% during the second quarter, Holdings Channel.com reports. The fund owned 161,215 shares of the medical technology company’s stock after purchasing an additional 18,866 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp’s holdings in Stryker were worth $50,757,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in SYK. Godfrey Financial Associates Inc. purchased a new position in shares of Stryker in the 4th quarter worth about $26,000. Sankala Group LLC purchased a new stake in shares of Stryker during the 4th quarter worth about $26,000. United Financial Planning Group LLC purchased a new stake in shares of Stryker during the 3rd quarter worth about $27,000. Atlas Capital Advisors Inc. acquired a new stake in Stryker during the 4th quarter worth approximately $27,000. Finally, DJE Kapital AG purchased a new position in Stryker in the fourth quarter valued at approximately $28,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. JPMorgan Chase & Co. reduced their price target on shares of Stryker from $400.00 to $350.00 and set an “overweight” rating on the stock in a research report on Friday, July 31st. Evercore set a $350.00 price objective on shares of Stryker in a research report on Monday, July 6th. Citigroup reissued a “buy” rating on shares of Stryker in a research note on Thursday. BTIG Research reduced their target price on shares of Stryker from $371.00 to $358.00 and set a “buy” rating on the stock in a report on Friday, July 31st. Finally, Leerink Partners decreased their price target on shares of Stryker from $410.00 to $407.00 and set an “outperform” rating for the company in a research report on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, Stryker has a consensus rating of “Moderate Buy” and an average target price of $386.28.

Insider Activity

In other Stryker news, VP Robert S. Fletcher sold 4,544 shares of the firm’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $306.87, for a total value of $1,394,417.28. Following the transaction, the vice president owned 10,582 shares of the company’s stock, valued at $3,247,298.34. This trade represents a 30.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Ronda E. Stryker sold 310,000 shares of Stryker stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $312.23, for a total value of $96,791,300.00. Following the completion of the transaction, the director owned 1,924,880 shares of the company’s stock, valued at approximately $601,005,282.40. The trade was a 13.87% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 4.60% of the company’s stock.

Stryker Price Performance

Shares of NYSE SYK opened at $338.80 on Monday. Stryker Corporation has a twelve month low of $281.00 and a twelve month high of $396.86. The company has a current ratio of 2.16, a quick ratio of 1.33 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $129.95 billion, a price-to-earnings ratio of 35.11, a price-to-earnings-growth ratio of 2.16 and a beta of 0.76. The business has a 50 day simple moving average of $324.61 and a 200-day simple moving average of $333.40.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.49 by $0.20. The firm had revenue of $6.59 billion for the quarter, compared to analysts’ expectations of $6.58 billion. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The firm’s revenue for the quarter was up 9.4% on a year-over-year basis. During the same period last year, the business posted $3.13 earnings per share. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, equities research analysts expect that Stryker Corporation will post 15.02 earnings per share for the current year.

Stryker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a $0.88 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.52 annualized dividend and a dividend yield of 1.0%. Stryker’s payout ratio is 36.48%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.